Get the Stockscreener App
6.72
3.72%
-0.26
Pre-market:
6.72
Treace Medical Concepts Inc stock is traded at $6.72, with a volume of 573.87K.
It is down -3.72% in the last 24 hours and down -0.59% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$6.98
Open:
$7.02
24h Volume:
573.87K
Relative Volume:
1.35
Market Cap:
$452.92M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-6.5741
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-6.67%
1M Performance:
-0.59%
6M Performance:
-11.93%
1Y Performance:
+34.40%
1-Day Range:
$6.55
$7.14
1-Week Range:
$5.895
$7.70
52-Week Range:
$4.54
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
6.72 | 452.92M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
128.56 | 233.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 155.05B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
386.32 | 146.77B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.25 | 106.66B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.75 | 44.02B | 5.54B | 4.18B | 623.10M | 7.00 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Cubist Systematic Strategies LLC Reduces Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Class Action Lawsuit Filed: Treace Medical Concepts, Inc. (TMCI) – Join by June 10, 2025 – Contact Levi & Korsinsky - ACCESS Newswire
TMCI Stock News: Robbins LLP Reminds Treace Medical Concepts, Inc. Stockholders That They Can Lead the Class Action Lawsuit - marketscreener.com
June 10, 2025 Deadline Approaching: Join Class Action Against Treace Medical Concepts, Inc. (TMCI)Contact Levi & Korsinsky - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - StreetInsider
TMCI Investors Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit - PR Newswire
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Deadline Alert: Treace Medical Concepts, Inc. (TMCI) - GlobeNewswire
Deadline Alert: Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Morgan Stanley Cuts Price Target on Treace Medical Concepts to $8 From $10, Maintains Equalweight Rating - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical - Bluefield Daily Telegraph
We Discuss Why Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) CEO Compensation May Be Closely Reviewed - simplywall.st
TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
Lost Money on Treace Medical Concepts, Inc. (TMCI)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Shareholders That Lost Money on Treace Medical Concepts, Inc. (TMCI) Should Contact Levi & Korsinsky About Pending Class ActionTMCI - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
NVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming DeadlinesTMCI - PR Newswire
The Gross Law Firm Notifies Treace Medical Concepts, Inc. - GlobeNewswire
The Gross Law Firm Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit - Bluefield Daily Telegraph
Shareholders of Treace Medical Concepts, Inc. Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your RightsTMCI - ACCESS Newswire
Scott+Scott Attorneys at Law LLP Reminds Investors of Its - GlobeNewswire
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI) - TradingView
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Treace Medical Concepts, Inc. (TMCI) Shareholders - ACCESS Newswire
Alert: Grabar Law Office is Investigating Claims on Behalf - GlobeNewswire
Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact The Gross Law Firm about pending Class ActionTMCI - PR Newswire
Raymond James Financial Inc. Makes New Investment in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
UBS Group Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $8.60 - Defense World
Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance
Treace Medical Concepts, Inc. Class Action: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025TMCI - ACCESS Newswire
Treace Medical Concepts, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationTMCI - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2025 Earnings Call Transcript - Insider Monkey
Stifel Financial Corp Buys 55,540 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Raymond James Financial Inc. Invests $392,000 in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts’ Earnings Call: Balancing Growth and Challenges - TipRanks
UBS Adjusts Price Target on Treace Medical Concepts to $8.60 From $10, Maintains Neutral Rating - marketscreener.com
Scott+Scott Attorneys at Law LLP Reminds Investors of the - GlobeNewswire
2025-05-09 | TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:TMCI | Press Release - Stockhouse
Treace Medical Concepts: Q1 Earnings Snapshot - New Haven Register
Investors who lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about pending Class ActionTMCI - ACCESS Newswire
Treace Medical Concepts Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Treace Medical Concepts Reports First Quarter 2025 Financial Results - The Manila Times
Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & ... - Bluefield Daily Telegraph
Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about pending Class ActionTMCI - ACCESS Newswire
The Gross Law Firm Notifies Shareholders of Treace Medical Concepts, Inc.(TMCI) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.22%
2.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):